Vitamin D receptor (VDR) is localized in nuclei and acts as a ligand-dependent transcription factor. To clarify the molecular mechanisms underlying the nuclear translocation of VDR, we utilized an in vitro nuclear transport assay using digitonin-permeabilized semi-intact cells. In this assay, recombinant whole VDR-(4 -427) and a truncated mutant VDR-(4 -232) lacking the carboxyl terminus of VDR were imported to nuclei even in the absence of ligand. In contrast, VDR-(91-427) lacking the amino-terminal DNA-binding domain was not imported to nuclei in the absence of ligand, and was efficiently imported in its liganded form. These results suggested that there are two distinct mechanisms underlying the nuclear transport of VDR; ligand-dependent and -independent pathways, and that the different regions of VDR are responsible for these processes. Therefore, we performed the yeast two-hybrid screening using VDR-(4 -232) as the bait to explore the molecules responsible for ligand-independent nuclear translocation of VDR, and have identified importin 4 as an interacting protein. In the reconstruction experiments where transport factors were applied as recombinant proteins, recombinant importin 4 facilitated nuclear translocation of VDR regardless of its ligand, whereas importin  failed in transporting VDR even in the presence of ligand. In conclusion, importin 4, not importin , is responsible for the ligandindependent nuclear translocation of VDR.The active form of vitamin D, 1␣,25-dihydroxyvitamin D 3 (1␣,25(OH) 2 D 3 ) 3 regulates various biological events through its direct actions on gene expression in its target organs such as intestine, kidney, and bone (1, 2). Its cognate receptor, vitamin D receptor (VDR), belongs to the nuclear receptor superfamily, and plays crucial roles in the physiological actions of 1␣,25(OH) 2 D 3 , including calcium homeostasis and bone metabolism (1, 2). Nuclear receptors including VDR act as ligandinducible transcription factors, and consist of several functional domains to regulate the expression of the target genes (1-3). Utilizing its DNA-binding domain, VDR recognizes a vitamin D-responsive element (VDRE) in the target genes, and regulates the expressions via forming complexes with retinoid X receptor (RXR) and transcriptional co-factors on its ligand-binding domain. To fulfill these events on the genome, nuclear receptors must be localized in nuclei. However, it seems that the subcellular distributions of the nuclear receptors do not resemble each other, unlike their transcriptional regulatory systems. Several reports have demonstrated that VDR is located in nuclei even in the absence of 1␣,25(OH) 2 D 3 and is accumulated in nuclei to a greater extent by addition of the ligand (4 -6). These observations are in contrast with the cases of other nuclear receptors, glucocorticoid receptor or estrogen receptor; the former translocates from the cytoplasm into nuclei only in the presence of the ligand, and the latter is located in nuclei regardless of the ligand (7, 8). The obvious diffe...